- Other degenerative brain diseases such as Alzheimer's
- Co-development & exclusive right of domestic sales and distribution
AAV vector-based gene therapy (RY104 [NG101])
- Acute neurological disease and neurodegenerative disease, etc.
- Co-development & exclusive right of worldwide production and distribution on NG101’s drug substance(DS) and drug product(DP).
Gene therapy platform technology
- Gene transfer and increased expression in vivo
- Co-development of ElectroPorator
- Patented technology for gene transfer and increased expression in vivo - Development and production of normal human cell lines for biopharmaceutical research/production
Gene therapy drugs (GB102)
- Chronic renal failure and ischemic heart disease
PDRN
- Tissue regeneration (95% similar to human DNA)/PDRN-based specialty drug development and commercialization
Natural medicine, health functional food
- Promoting new development through strategic cooperation between REYON Pharmaceutical, FINZELBERG, and G&P for various indications
Antifungal Drug (RY108)
- Technical transfer of a patented technology of antifungal agent ‘iN-EYD’ of the new mechanism of action
pDNA-based cancer vaccine (RY109)
- Co-development of pDNA-based cancer vaccine for ovarian cancer
NK Cell Therapy (RY110 [TB-100])
- Co-development of iPSC-derived NK Cell therapy for solid tumor
- Supply of pDNA Drug Substance for producing NK Cell Therapy